Cargando…
De Novo Emergence of Mesenchymal Stem-Like CD105(+) Cancer Cells by Cytotoxic Agents in Human Hepatocellular Carcinoma()()
BACKGROUND: Cancer stem cells (CSCs) are considered a pivotal target for the eradication of hepatocellular carcinoma (HCC). Recently, we reported that the CSC markers epithelial cell adhesion molecule (EpCAM) and CD90 are expressed independently in primary HCCs and cell lines, and CD90(+) cells shar...
Autores principales: | Nomura, Yoshimoto, Yamashita, Taro, Oishi, Naoki, Nio, Kouki, Hayashi, Takehiro, Yoshida, Mariko, Hayashi, Tomoyuki, Hashiba, Tomomi, Asahina, Yasuhiro, Okada, Hikari, Sunagozaka, Hajime, Takatori, Hajime, Honda, Masao, Kaneko, Shuichi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Neoplasia Press
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5299205/ https://www.ncbi.nlm.nih.gov/pubmed/28182993 http://dx.doi.org/10.1016/j.tranon.2017.01.005 |
Ejemplares similares
-
Sorafenib suppresses extrahepatic metastasis de novo in hepatocellular carcinoma through inhibition of mesenchymal cancer stem cells characterized by the expression of CD90
por: Yoshida, Mariko, et al.
Publicado: (2017) -
Sporadic PCDH18 somatic mutations in EpCAM-positive hepatocellular carcinoma
por: Hayashi, Takehiro, et al.
Publicado: (2017) -
Beta-Hydroxyisovaleryl-Shikonin Eradicates Epithelial Cell Adhesion Molecule-Positive Liver Cancer Stem Cells by Suppressing dUTP Pyrophosphatase Expression
por: Asahina, Yoshiro, et al.
Publicado: (2023) -
Serum cytokine profiles predict survival benefits in patients with advanced hepatocellular carcinoma treated with sorafenib: a retrospective cohort study
por: Hayashi, Tomoyuki, et al.
Publicado: (2017) -
Inactivation of Transcriptional Repressor Capicua Confers Sorafenib Resistance in Human Hepatocellular Carcinoma
por: Hashiba, Tomomi, et al.
Publicado: (2020)